These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32590884)

  • 1. Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-NTRK3 fusion, and the rare KLHL7-BRAF fusion.
    Zhao M; Yin M; Kuick CH; Chen H; Aw SJ; Merchant K; Ng EHQ; Gunaratne S; Loh AHP; Gu W; Tang H; Chang KTE
    Histopathology; 2020 Oct; 77(4):611-621. PubMed ID: 32590884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Fibromatosis Lacks the Internal Tandem Duplication of EGFR Seen in Congenital Mesoblastic Nephroma.
    Chami R; Marrano P; Thorner PS
    Genes Chromosomes Cancer; 2024 Sep; 63(9):e23266. PubMed ID: 39248534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.
    Rubin BP; Chen CJ; Morgan TW; Xiao S; Grier HE; Kozakewich HP; Perez-Atayde AR; Fletcher JA
    Am J Pathol; 1998 Nov; 153(5):1451-8. PubMed ID: 9811336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.
    Knezevich SR; Garnett MJ; Pysher TJ; Beckwith JB; Grundy PE; Sorensen PH
    Cancer Res; 1998 Nov; 58(22):5046-8. PubMed ID: 9823307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infantile fibrosarcoma with an EGFR kinase domain duplication: Underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum.
    van Spronsen R; Kester LA; Knops RRG; van de Sande MAJ; van Leenders GJLH; de Laat PCJ; Stortelder E; Korpershoek E; van Noesel MM; Meister MT; Koerkamp MJAG; de Graaf N; Giovannoni I; Tops BBJ; de Krijger RR; Ter Horst SAJ; Flucke U; Alaggio R; Hiemcke-Jiwa LS
    Ann Diagn Pathol; 2022 Apr; 57():151885. PubMed ID: 35032896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
    Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
    Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors.
    Argani P; Fritsch M; Kadkol SS; Schuster A; Beckwith JB; Perlman EJ
    Mod Pathol; 2000 Jan; 13(1):29-36. PubMed ID: 10658907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis.
    Watanabe N; Kobayashi H; Hirama T; Kikuta A; Koizumi S; Tsuru T; Kaneko Y
    Cancer Genet Cytogenet; 2002 Jul; 136(1):10-6. PubMed ID: 12165445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.
    Misove A; Vicha A; Zapotocky M; Malis J; Balko J; Nemeckova T; Szabova J; Kyncl M; Novakova-Kodetova D; Stolova L; Jencova P; Broz P; Krskova L
    Genes Chromosomes Cancer; 2021 Dec; 60(12):837-840. PubMed ID: 34378283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors.
    Csanyi-Bastien M; Lanic MD; Beaussire L; Ferric S; François A; Meseure D; Jardin F; Wassef M; Ruminy P; Laé M
    Am J Surg Pathol; 2021 Nov; 45(11):1487-1498. PubMed ID: 33899788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement.
    El Demellawy D; Cundiff CA; Nasr A; Ozolek JA; Elawabdeh N; Caltharp SA; Masoudian P; Sullivan KJ; de Nanassy J; Shehata BM
    Pathology; 2016 Jan; 48(1):47-50. PubMed ID: 27020209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study.
    Gadd S; Beezhold P; Jennings L; George D; Leuer K; Huang CC; Huff V; Tognon C; Sorensen PH; Triche T; Coffin CM; Perlman EJ
    J Pathol; 2012 Sep; 228(1):119-30. PubMed ID: 22374738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma.
    Lei L; Stohr BA; Berry S; Lockwood CM; Davis JL; Rudzinski ER; Kunder CA
    Pract Lab Med; 2020 Aug; 21():e00164. PubMed ID: 32490123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ETV6-NTRK in classical, cellular and mixed subtypes of congenital mesoblastic nephroma.
    Anderson J; Gibson S; Sebire NJ
    Histopathology; 2006 May; 48(6):748-53. PubMed ID: 16681692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors.
    Rudzinski ER; Lockwood CM; Stohr BA; Vargas SO; Sheridan R; Black JO; Rajaram V; Laetsch TW; Davis JL
    Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma.
    Yamamoto H; Nozaki Y; Sugii A; Taguchi K; Hongo T; Jiromaru R; Sato M; Nakano T; Hashimoto K; Fujiwara M; Oda Y
    Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR internal tandem duplications in fusion-negative congenital and neonatal spindle cell tumors.
    Koo SC; Schieffer KM; Lee K; Gupta A; Pfau RB; Avenarius MR; Stonerock E; LaHaye S; Fitch J; Setty BA; Roberts R; Ranalli M; Conces MR; Bu F; Mardis ER; Cottrell CE
    Genes Chromosomes Cancer; 2023 Jan; 62(1):17-26. PubMed ID: 35801295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAF1 gene fusions are recurrent driver events in infantile fibrosarcoma-like mesenchymal tumors.
    Motta M; Barresi S; Pizzi S; Bifano D; Lopez Marti J; Garrido-Pontnou M; Flex E; Bruselles A; Giovannoni I; Rotundo G; Fragale A; Tirelli V; Vallese S; Ciolfi A; Bisogno G; Alaggio R; Tartaglia M
    J Pathol; 2024 Jun; 263(2):166-177. PubMed ID: 38629245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma.
    Halalsheh H; McCarville MB; Neel M; Reynolds M; Cox MC; Pappo AS
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27271. PubMed ID: 29893456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETV6-NTRK3 in congenital mesoblastic nephroma: A report of the SIOP/GPOH nephroblastoma study.
    Vokuhl C; Nourkami-Tutdibi N; Furtwängler R; Gessler M; Graf N; Leuschner I
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.